Pricing

Acorda Therapeutics Inc (ACORQ)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Ronald Cohen
Employees:
130
TWO BLUE HILL PLAZA, PEARL RIVER, NY, 10965
914-347-4300
Stock Split History
DateRatio
2021-01-04 1:6
2023-06-05 1:20
Acorda Therapeutics, Inc. develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS) Inbrija for the treatment of OFF periods in Parkinson's disease in Europe.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available